We are live on ! Find out more
LYRA

LYRA THERAPEUTICS INC

Delisted

LYRA was delisted on the 16th of March, 2026.

44 hedge funds and large institutions have $55.9M invested in LYRA THERAPEUTICS INC in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 21 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.09% less ownership

Funds ownership: 1.17%1.07% (-0.09%)

10% less funds holding

Funds holding: 4944 (-5)

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

36% less capital invested

Capital invested by funds: $87.6M → $55.9M (-$31.7M)

86% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 21

Holders
44
Holders Change
-5
Holders Change %
-10.2%
% of All Funds
0.77%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
3
Reduced
21
Closed
16
Calls
Puts
Net Calls
Net Calls Change

LYRA Hedge Fund Activity: Q2 2021 in Review

44 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q2 2021, worth a combined $55.9M — down 36% from $87.6M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of LYRA and 11 opened new positions — a net loss of 5 holders — while 21 trimmed existing stakes and 3 added.

The largest buyer was Pura Vida Investments, opening a new position worth an estimated $4.94M. The largest seller was BlackRock, cutting an estimated $2.99M.

  • 44 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q2 2021, down from 49 in Q1 2021.
  • Funds reported $55.9M of LYRA THERAPEUTICS INC stock for Q2 2021, down 36% quarter-over-quarter.
  • 11 funds opened new LYRA THERAPEUTICS INC positions in Q2 2021 and 16 closed out, a net change of -5 holders.
  • The largest LYRA THERAPEUTICS INC buyer in Q2 2021 was Pura Vida Investments, an estimated $4.94M added.
  • The largest LYRA THERAPEUTICS INC seller in Q2 2021 was BlackRock, an estimated $2.99M sold.

Based on aggregated 13F filings for Q2 2021.